Literature DB >> 18973749

Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells.

Eun Jeong Choi1, Woong Shick Ahn, Su Mi Bae.   

Abstract

This study investigated the role of the caspase activation cascade in extrinsic and intrinsic apoptosis induced by equol in human breast cancer MDA-MB cells. First, the antiproliferative effect of equol was determined in cells treated with 1-100 microM equol for 24, 48, and 72h. Equol significantly inhibited cell proliferation in a dose-dependent manner (p<0.05). Exposure to 50 or 100 microM equol for 72h strongly promoted apoptosis. Under the same conditions, remarkable cytochrome c release was observed. Subsequently, caspase-9, which acts in mitochondria-mediated apoptosis, was cleaved by equol at high concentrations, but caspase-8 activation of receptor-mediated apoptosis was not observed. At both equol concentrations, the caspase-8 and -9 activity assays showed similar patterns. In addition, equol treatment activated caspase-3, which is downstream from caspase-9, and this was accompanied by the cleavage of capase-6 and -7. Activation of these caspases leads to increased activation of PARP, lamin, and ICAD. This study suggests that equol induces the intrinsic pathway of apoptosis via caspase-9 and cytochrome c, independent of caspase-8, in human breast cancer MDA-MB-453 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973749     DOI: 10.1016/j.cbi.2008.09.031

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  15 in total

Review 1.  A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects.

Authors:  Harold Tjalsma; Annemarie Boleij; Julian R Marchesi; Bas E Dutilh
Journal:  Nat Rev Microbiol       Date:  2012-06-25       Impact factor: 60.633

2.  The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer.

Authors:  Nadine M Brown; Carrie A Belles; Stephanie L Lindley; Linda D Zimmer-Nechemias; Xueheng Zhao; David P Witte; Mi-Ok Kim; Kenneth D R Setchell
Journal:  Carcinogenesis       Date:  2010-01-28       Impact factor: 4.944

3.  6,7,4'-trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2.

Authors:  Dong Eun Lee; Ki Won Lee; Sung Keun Jung; Eun Jung Lee; Jung A Hwang; Tae-Gyu Lim; Bo Yeon Kim; Ann M Bode; Hyong Joo Lee; Zigang Dong
Journal:  Carcinogenesis       Date:  2011-01-21       Impact factor: 4.944

4.  Growth inhibition and apoptotic effect of alpha-eleostearic acid on human breast cancer cells.

Authors:  Tingting Zhang; Yanping Gao; Yu Mao; Quanbo Zhang; Caiyu Lin; Ping Lin; Jie Zhang; Xiujie Wang
Journal:  J Nat Med       Date:  2011-06-21       Impact factor: 2.343

5.  Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.

Authors:  Columba de la Parra; Luis D Borrero-Garcia; Ailed Cruz-Collazo; Robert J Schneider; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

6.  Anti-bacterial and Anti-biofilm Effects of Equol on Yersinia enterocolitica.

Authors:  Hye-Rim Kim; Mi-Suk Han; Yong-Bin Eom
Journal:  Indian J Microbiol       Date:  2022-04-18

7.  The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.

Authors:  Columba de la Parra; Elisa Otero-Franqui; Michelle Martinez-Montemayor; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

8.  Towards the human colorectal cancer microbiome.

Authors:  Julian R Marchesi; Bas E Dutilh; Neil Hall; Wilbert H M Peters; Rian Roelofs; Annemarie Boleij; Harold Tjalsma
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

9.  Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells.

Authors:  Christiana Charalambous; Chara A Pitta; Andreas I Constantinou
Journal:  BMC Cancer       Date:  2013-05-15       Impact factor: 4.430

10.  (±)Equol inhibits invasion in prostate cancer DU145 cells possibly via down-regulation of matrix metalloproteinase-9, matrix metalloproteinase-2 and urokinase-type plasminogen activator by antioxidant activity.

Authors:  Wei Zheng; Yumei Zhang; Defu Ma; Yuhui Shi; Changqiu Liu; Peiyu Wang
Journal:  J Clin Biochem Nutr       Date:  2012-03-30       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.